T. Rowe Price Investment Management, Inc. Insmed Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,451,580 shares of INSM stock, worth $243 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,451,580
Previous 5,850,606
41.0%
Holding current value
$243 Million
Previous $181 Million
48.35%
% of portfolio
0.06%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding INSM
# of Institutions
343Shares Held
141MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$1.02 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$829 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$757 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$415 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$336 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.52B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...